These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Meigs JB; D'Agostino RB; Wilson PW; Cupples LA; Nathan DM; Singer DE Diabetes; 1997 Oct; 46(10):1594-600. PubMed ID: 9313755 [TBL] [Abstract][Full Text] [Related]
4. [Correlation between insulin resistance and puberty in children with increased cardiometabolic risk]. Tobisch B; Blatniczky L; Barkai L Orv Hetil; 2011 Jul; 152(27):1068-74. PubMed ID: 21676673 [TBL] [Abstract][Full Text] [Related]
5. Association between insulin resistance, glucose intolerance, and hypertension in pregnancy. Negrato CA; Jovanovic L; Tambascia MA; Geloneze B; Dias A; Calderon Ide M; Rudge MV Metab Syndr Relat Disord; 2009 Feb; 7(1):53-9. PubMed ID: 18847384 [TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance. Amoah AG; Schuster DP; Gaillard T; Osei K Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of diabetes and impaired glucose tolerance in Aragón, Spain. Tamayo-Marco B; Faure-Nogueras E; Roche-Asensio MJ; Rubio-Calvo E; Sánchez-Oriz E; Salvador-Oliván JA Diabetes Care; 1997 Apr; 20(4):534-6. PubMed ID: 9096976 [TBL] [Abstract][Full Text] [Related]
8. Obesity, diabetes, and hyperlipidemia in a central Australian aboriginal community with a long history of acculturation. O'Dea K; Patel M; Kubisch D; Hopper J; Traianedes K Diabetes Care; 1993 Jul; 16(7):1004-10. PubMed ID: 8359092 [TBL] [Abstract][Full Text] [Related]
9. Impaired glucose tolerance, diabetes, and cardiovascular disease risk factor profiles in the elderly. The Honolulu Heart Program. Rodriguez BL; Curb JD; Burchfiel CM; Huang B; Sharp DS; Lu GY; Fujimoto W; Yano K Diabetes Care; 1996 Jun; 19(6):587-90. PubMed ID: 8725856 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study. Nijpels G; Popp-Snijders C; Kostense PJ; Bouter LM; Heine RJ J Clin Epidemiol; 1997 Sep; 50(9):1003-9. PubMed ID: 9363034 [TBL] [Abstract][Full Text] [Related]
11. Higher Waist Circumference, Fasting Hyperinsulinemia And Insulin Resistance Characterize Hypertensive Patients With Impaired Glucose Metabolism. De Pergola G; Nardecchia A; Cirillo M; Boninfante B; Sciaraffia M; Giagulli VA; Triggiani V; Silvestris F Endocr Metab Immune Disord Drug Targets; 2015; 15(4):297-301. PubMed ID: 25944063 [TBL] [Abstract][Full Text] [Related]
12. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas]. Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Isomaa B; Almgren P; Tuomi T; Forsén B; Lahti K; Nissén M; Taskinen MR; Groop L Diabetes Care; 2001 Apr; 24(4):683-9. PubMed ID: 11315831 [TBL] [Abstract][Full Text] [Related]
14. Comparison of ADA and WHO criteria for the diagnosis of diabetes in elderly Koreans. Choi KM; Lee J; Kim DR; Kim SK; Shin DH; Kim NH; Park IB; Choi DS; Baik SH Diabet Med; 2002 Oct; 19(10):853-7. PubMed ID: 12358874 [TBL] [Abstract][Full Text] [Related]
15. Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors. Du T; Yuan G; Zhou X; Sun X Ann Med; 2016; 48(1-2):34-41. PubMed ID: 26758477 [TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians. Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814 [TBL] [Abstract][Full Text] [Related]
17. Use of metabolic markers to identify overweight individuals who are insulin resistant. McLaughlin T; Abbasi F; Cheal K; Chu J; Lamendola C; Reaven G Ann Intern Med; 2003 Nov; 139(10):802-9. PubMed ID: 14623617 [TBL] [Abstract][Full Text] [Related]
18. Hyperinsulinemia and clustering of cardiovascular risk factors in middle-aged hypertensive Finnish men and women. Vanhala MJ; Kumpusalo EA; Pitkäjärvi TK; Notkola IL; Takala JK J Hypertens; 1997 May; 15(5):475-81. PubMed ID: 9169999 [TBL] [Abstract][Full Text] [Related]
19. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome. Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253 [TBL] [Abstract][Full Text] [Related]
20. The association of the insulin resistance syndrome with impaired glucose tolerance and NIDDM in the Japanese general population: the Hisayama study. Ohmura T; Ueda K; Kiyohara Y; Kato I; Iwamoto H; Nakayama K; Nomiyama K; Ohmori S; Yoshitake T; Shinkawa A Diabetologia; 1994 Sep; 37(9):897-904. PubMed ID: 7806019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]